生长分化因子-15与血管外肺水指数在急性呼吸窘迫综合征严重程度分级及预后预测中的价值
该研究纳入82例RICU的ARDS患者(18-75岁),按2012柏林定义分为轻、中、重度,均接受常规治疗并置入PiCCO监测EVLWI,同时用ELISA测血清GDF-15。中、重度ARDS各时间点GDF-15和EVLWI多高于轻度,重度多高于中度。提示两指标可在一定程度上反映ARDS严重程度并与不良预后相关。
要点
- 以EVLWI 15 mL/kg为界,高值组28天死亡率47.8% vs 低值组17.4%(P<0.05),ICU住院18.45±2.61天 vs 14.98±2.75天。
- 中、重度ARDS各时间点GDF-15和EVLWI多高于轻度组,重度多高于中度组(仅治疗24小时GDF-15差异P>0.05)。
- EVLWI需PiCCO监测获取,GDF-15用ELISA测定;两指标均为观察性关联,原文未给出作为决策阈值的推荐。
适用人群与场景
- 2019年1月至2020年2月郑州大学附属郑州中心医院RICU收治的18-75岁ARDS患者,共82例(轻度22例、中度28例、重度32例)。
- 所有患者按病情接受机械通气、抗感染、稳定水电解质及酸碱环境、血液净化和营养支持等常规治疗,入院后行PiCCO监测。
诊断标准与关键阈值
- 按2012年柏林定义将ARDS分为轻度、中度、重度。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型为单中心观察性研究,纳入82例ARDS患者,无对照组干预比较。
- EVLWI高值组(≥15 mL/kg)ICU住院时间18.45±2.61天 vs 低值组14.98±2.75天,28天死亡率47.8% vs 17.4%(均P<0.05)。
证据类型、等级与局限
- 证据类型为单中心观察性研究,样本量82例,无随机对照,未提及证据等级。
- 局限:单中心、样本小、观察性设计,GDF-15及EVLWI界值来自本研究,需前瞻性验证。
对床旁实践的改变
- 该研究为观察性关联,不能据此将两界值作为启动或停止治疗的决策阈值;原文未给出基于该指标的干预方案。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the value of growth differentiation factor-15 (GDF-15) and extravascular lung water index (EVLWI) in severity grading and prognosis prediction of patients with acute respiratory distress syndrome (ARDS).
METHODS: Patients with ARDS aged 18-75 years admitted to the department of respiratory intensive care unit (RICU) of Zhengzhou Central Hospital Affiliated to Zhengzhou University from January 2019 to February 2020 were enrolled. All patients were treated with conventional therapies such as mechanical ventilation, anti-infection, stabilization of water, electrolytes and acid-base environment, blood purification and nutritional support according to their conditions. Besides, the pulse-indicated continuous cardiac output (PiCCO) was performed after admission to the department, and EVLWI before treatment and at 24, 48 and 72 hours of treatment were recorded. Serum GDF-15 level was measured by enzyme linked immunosorbent assay (ELISA) during the same period. Patients were classified as mild, moderate, and severe degree according to the 2012 Berlin Definition of ARDS, and EVLWI and GDF-15 levels in patients with different disease levels before and after treatment were compared. In addition, the length of intensive care unit (ICU) stay, ICU mortality, and 28-day mortality of patients with different GDF-15 or EVLWI levels were analyzed comparatively, with the GDF-15 3 458 ng/L and EVLWI 15 mL/kg as the cut point.
RESULTS: A total of 82 patients with ARDS were enrolled, including 22 patients with mild ARDS, 28 patients with moderate ARDS, and 32 patients with severe ARDS. The GDF-15 and EVLWI levels in patients with moderate and severe ARDS at each time point before and after treatment were higher than those in patients with mild ARDS. Both GDF-15 and EVLWI levels in patients with severe ARDS were higher than those in the patients with moderate ARDS. The differences were statistically significant at all the time points except for the difference of GDF-15 levels at 24 hours after treatment (ng/L: 3 900.41±546.43 vs. 3 695.66±604.73, P > 0.05). [GDF-15 (ng/L): 3 786.11±441.45 vs. 3 106.83±605.09 before treatment, 3 895.48±558.96 vs. 3 333.29±559.66 at 48 hours, 3 397.33±539.56 vs. 3 047.53±499.57 at 72 hours; EVLWI (mL/kg): 19.06±1.91 vs. 14.31±1.50 before treatment, 18.56±2.23 vs. 13.26±1.69 at 24 hours, 17.23±1.76 vs. 12.45±1.36 at 48 hours, 15.47±1.81 vs. 11.13±2.19 at 72 hours, all P < 0.05]. According to the cut-off value, there were 23 patients with GDF-15 ≥ 3 458 ng/L and GDF-15 < 3 458 ng/L respectively and there were 23 patients with EVLWI ≥ 15 mL/kg and EVLWI < 15 mL/kg respectively. The length of ICU stay and 28-day mortality in patients with high GDF-15 were significantly higher than those in patients with low GDF-15 [length of ICU stay (days): 21.22±2.69 vs. 15.37±3.14, 28-day mortality: 56.5% vs. 21.7%, both P < 0.05]. The length of ICU stay and 28-day mortality in patients with high EVLWI were also significantly higher than those in patients with low EVLWI [length of ICU stay (days): 18.45±2.61 vs. 14.98±2.75, 28-day mortality: 47.8% vs. 17.4%, both P < 0.05].
CONCLUSIONS: To some extent, GDF-15 and EVLWI levels reflect the severity of patients with ARDS, and high GDF-15 and EVLWI levels are significantly associated with poor prognosis in patients with ARDS.
参考来源
- Shang M, Gao Y, Jia B, et al. [The value of growth differentiation factor-15 and extravascular lung water index in severity grading of acute respiratory distress syndrome patients and their prognosis prediction]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020. PMID: 33198869. doi:10.3760/cma.j.cn121430-20200407-00257
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。